The ISOSAT Small Satellite: A Design in Isogrid Technology

ISOSAT, a small hexagonal shaped satellite structure, was designed and constructed in the Industrial Technology Department at Utah State University as a senior research project using automated manufacturing techniques and incorporating the Isogrid structure concept. Isogrid applications can be found in projects such as Skylab, most cylindrical structural elements of the Delta rocket and in the engine shrouds of Boeing\u27s new 777 commercial airliners. The basis of the Isogrid is the repeating pattern of equilateral triangles which make up the structure. This pattern, machined into solid aluminum plates, results in a substantial weight savings with an acceptable reduction in structural strength. The intersections of adjacent triangles are referred to as nodes. These nodes serve as uniformly distributed attachment points for the mounting of instrumentation and other hardware

Computational investigation of noble gas adsorption and separation by nanoporous materials.

Molecular simulations are used to assess the ability of metal-organic framework (MOF) materials to store and separate noble gases. Specifically, grand canonical Monte Carlo simulation techniques are used to predict noble gas adsorption isotherms at room temperature. Experimental trends of noble gas inflation curves of a Zn-based material (IRMOF-1) are matched by the simulation results. The simulations also predict that IRMOF-1 selectively adsorbs Xe atoms in Xe/Kr and Xe/Ar mixtures at total feed gas pressures of 1 bar (14.7 psia) and 10 bar (147 psia). Finally, simulations of a copper-based MOF (Cu-BTC) predict this material's ability to selectively adsorb Xe and Kr atoms when present in trace amounts in atmospheric air samples. These preliminary results suggest that Cu-BTC may be an ideal candidate for the pre-concentration of noble gases from air samples. Additional simulations and experiments are needed to determine the saturation limit of Cu-BTC for xenon, and whether any krypton atoms would remain in the Cu-BTC pores upon saturation

Fuel purification, Lewis acid and aerobic oxidation catalysis performed by a microporous Co-BTT (BTT3-=1,3,5-benzenetristetrazolate) framework having coordinatively unsaturated sites

[EN] Two isostructural microporous metal-organic frameworks [Co(DMA)(6)](3)[(Co4Cl)(3-)(BTT)(8)(H2O)(12)](2)center dot 12H2O (BTT3- = 1,3,5-benzenetristetrazolate; DMA N,N'-dimethylacetamide) (1) and [Cd(DMF)(6)](3)[(Cd4Cl)(3)(BTT)(8)(H2O)(12)](2)center dot 14H(2)O center dot 4DMF (DMF = N,N'-dimethylformamide) (2) were synthesized under solvothermal conditions. The structures of both compounds were determined by single-crystal X-ray diffraction data. Each compound adopts a porous three-dimensional framework consisting of square-planar [M4Cl](7+) (M2+ = Co, 1; Cd, 2) units interconnected by triangular tritopic BTT3- bridging ligands to give an anionic (3,8)-connected "Moravia" net. Phase purity of the compounds was confirmed by X-ray powder diffraction (XRPD), IR spectroscopy, thermogravimetric (TG) and elemental analysis. TGA and temperature-dependent XRPD (TDXRPD) experiments indicate a moderate thermal stability up to 350 and 300 degrees C, respectively. Guest exchange followed by heating led to microporous solids with coordinatively unsaturated metal sites. These unsaturated metal sites create opportunities in adsorptive and catalytic applications. These have been probed by the selective removal of sulfur compounds from fuel feeds as well as the catalytic ring opening of styrene oxide and the oxidation of several cycloalkanes and benzyl compounds.The Deutsche Forschungsgemeinschaft (DFG, SPP 1362 "Porous Metal-Organic Frameworks" under the grant STO 643/5-2) is gratefully acknowledged for the financial support. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 228862.Biswas, S.; Maes, M.; Amarajothi, D.; Feyand, M.; De Vos, DE.; García Gómez, H.; Stock, N. (2012). Fuel purification, Lewis acid and aerobic oxidation catalysis performed by a microporous Co-BTT (BTT3-=1,3,5-benzenetristetrazolate) framework having coordinatively unsaturated sites. Journal of Materials Chemistry. 22(20):10200-10209. https://doi.org/10.1039/c2jm15592cS1020010209222

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension

Mark GreathouseSouth Hills Cardiology Associates of Pittsburgh, Pittsburgh, PA, USAAbstract: In most patients with hypertension, especially Stage 2 hypertension, adequate control of blood pressure (BP) is only achieved with combination drug therapy. When using combination therapy, antihypertensive agents with complementary mechanisms of action are recommended, for example, an angiotensin receptor blocker (ARB) in combination with hydrochlorothiazide (HCTZ), a β-blocker + HCTZ, an ACE inhibitor + HCTZ, or a calcium channel blocker + an ACE inhibitor. One such combination is olmesartan medoxomil + HCTZ, which is available as fixed-dose, single-tablet combinations for once-daily administration. In clinical trials, olmesartan medoxomil/HCTZ reduced systolic BP (SBP) and diastolic BP (DBP) to a greater extent than either component as monotherapy. A clinical study in patients with Stage 1 or 2 hypertension showed that olmesartan medoxomil/HCTZ achieved a similar mean reduction in DBP, but a significantly greater mean reduction in SBP and higher rate of BP control (<140/90 mmHg) than observed with losartan/HCTZ, at US/European-approved starting doses. In a non-inferiority trial, the antihypertensive efficacy of olmesartan medoxomil/HCTZ was comparable to that of atenolol/HCTZ. Furthermore, indirect comparisons have shown that olmesartan medoxomil/HCTZ compares favorably with other antihypertensive combination therapies, including other ARB/HCTZ combinations and amlodipine besylate/benazepril. Olmesartan medoxomil/HCTZ is generally well tolerated. In conclusion, olmesartan medoxomil/HCTZ is an effective and well-tolerated combination antihypertensive therapy that results in significant BP reductions and BP control in many patients. Keywords: olmesartan medoxomil, hydrochlorothiazide, angiotensin II receptor blocker, hypertensio

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension-0

<p><b>Copyright information:</b></p><p>Taken from "Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension"</p><p></p><p>Vascular Health and Risk Management 2006;2(4):401-409.</p><p>Published online Jan 2006</p><p>PMCID:PMC1994014.</p><p>© 2006 Dove Medical Press Limited. All rights reserved</p